Lexaria Bioscience Corp. financial data

Symbol
LEXX, LEXXW on Nasdaq
Location
100 740 Mccurdy Road, Kelowna, British Columbia, Canada
State of incorporation
NV
Fiscal year end
August 31
Former names
Lexaria Corp. (to 5/11/2016), LEXARIA CORP. (to 5/11/2016)
Latest financial report
10-Q - Q4 2024 - Jan 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.91K % +144%
Quick Ratio 0.96 % -94.4%
Debt-to-equity 6.05 % -53%
Return On Equity -88.9 % +46.3%
Return On Assets -83.6 % +42.3%
Operating Margin -1.47K % +31.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares +68.2%
Common Stock, Shares, Outstanding 17.5M shares +69.3%
Entity Public Float 40.6M USD
Common Stock, Value, Issued 17.5K USD +69.3%
Weighted Average Number of Shares Outstanding, Diluted 16.7M shares +84.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 497K USD +77.6%
Revenue from Contract with Customer, Excluding Assessed Tax 184K USD +21.6%
Research and Development Expense 3.74M USD +9.6%
General and Administrative Expense 4.06M USD +43.7%
Operating Income (Loss) -7.3M USD -22.2%
Net Income (Loss) Attributable to Parent -7.32M USD -20.2%
Earnings Per Share, Diluted -0.16 USD/shares -23.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.27M USD -60.9%
Marketable Securities, Current 39.9K USD -44.9%
Accounts Receivable, after Allowance for Credit Loss, Current 263K USD -50.7%
Inventory, Net 0 USD -100%
Assets, Current 8.83M USD +228%
Property, Plant and Equipment, Net 271K USD +15.8%
Operating Lease, Right-of-Use Asset 143K USD
Assets 9.79M USD +170%
Liabilities, Current 298K USD +139%
Operating Lease, Liability, Noncurrent 102K USD
Liabilities 400K USD +57.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -23K USD -626%
Retained Earnings (Accumulated Deficit) -54.3M USD -15.6%
Stockholders' Equity Attributable to Parent 9.77M USD +161%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 9.39M USD +179%
Liabilities and Equity 9.79M USD +170%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.73M USD -131%
Net Cash Provided by (Used in) Financing Activities 4.35M USD +139%
Net Cash Provided by (Used in) Investing Activities -37.8K USD +5.55%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 17.5M shares +69.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.58M USD +162%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.08M USD +313%
Deferred Tax Assets, Valuation Allowance 10.7M USD +12%
Deferred Tax Assets, Gross 10.7M USD +12%
Operating Lease, Liability 143K USD
Payments to Acquire Property, Plant, and Equipment 24.6K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.35M USD -20.8%
Lessee, Operating Lease, Liability, to be Paid 151K USD -18.5%
Operating Lease, Liability, Current 28.8K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 28K USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 0 USD -100%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37.3K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38.6K USD 0%
Operating Lease, Payments 8.96K USD -80%
Additional Paid in Capital 64M USD +26.4%
Depreciation, Depletion and Amortization 8.73K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 99.4K USD +84.3%